Institut Gustave-Roussy Company Profile

20:18 EDT 19th June 2018 | BioPortfolio

The Institute Gustave-Roussy is a non-profit private institution, exclusively devoted to oncology.It is part of the French public hospital system.
State-approved, it is authorised to receive donations and legacies (Decree of October 1st 1945).


39 rue Camille
Villejuif Cedex


Phone: 00 33 1 42 11 42 11
Fax: 00 33 1 42 11 53

News Articles [77 Associated News Articles listed on BioPortfolio]

PEP-Therapy, Institut Curie and Gustave Roussy Obtain 2,9 M€ to Develop a Novel Peptide in Oncology

The partners join together to develop this new therapeutic approach up to clinical proof of concept PEP-Therapy, Institut Curie and Gustave Roussy join together to cond...

Gustave Roussy and Protagen AG Collaborate to Improve the Risk Profiling of Cancer Patients Undergoing Immunotherapy

Protagen AG and Gustave Roussy have today announced the start of a collaboration to utilize Protagen’s SeroTag® technology to help identify biomarkers that predict and monitor ...

Book release: 'Institut Pasteur: Today's Research, Tomorrow's Medicine'

(Institut Pasteur) As the Institut Pasteur enters the 130th year of its existence (the anniversary will be celebrated on Nov. 14, 2018), the book Institut Pasteur: Today's Research, Tomorrow's Medicin...

Institut Gustave Roussy Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 12032018] Prices from USD $250

SummaryInstitut Gustave Roussy IGR is a cancer research institute that offers healthcare services to patients suffering from cancer and conducts research to identify new therapies. The institute provi...

High incidence of neonatal infections in Madagascar

(Institut Pasteur) Every year in the world, 4 million children die before the age of one, mainly in resource-limited countries, one-third of them due to a severe infection. In 2012, the Institut Paste...

Yellow fever: A new method for testing vaccine safety

(Institut Pasteur) Scientists from the Institut Pasteur, the CNRS and Sanofi Pasteur have recently developed a novel alternative method to animal testing that can be used to verify the safety of vacci...

African Parks: Der Garamba Nationalpark in der DR Kongo schlägt zum 80. ...

Das Institut Congolais pour la Conservation de la Nature(ICCN, Kongolesisches Institut für Naturschutz) der Demokratischen Republik Kongo und African Parksfeierten am 13. Juni Read more...

Cannabis Report: ICC Labs - Big Deal mit Institut Pasteur - Zur Entwicklung von pharmazeutischen Produkten auf Basis von Cannabis hat ICC Labs mit dem Institut Pasteur in Uruguay ein Kooperationsabkommen unterzeichnet. Das Unternehmen will s...

Drugs and Medications [0 Results]


PubMed Articles [10 Associated PubMed Articles listed on BioPortfolio]

Organisational factors influencing early clinical trials enrollment: Gustave Roussy experience.

Enrolment process influences the likelihood of patients' inclusion in early clinical trials (ECT) through social, medical and organisational factors.

Relevance of a molecular tumour board (MTB) for patients' enrolment in clinical trials: experience of the Institut Curie.

High throughput molecular screening techniques allow the identification of multiple molecular alterations, some of which are actionable and can be targeted by molecularly targeted agents (MTA). We aim...

The new Pan-American Neuroendocrine Society.

The new Pan-American Neuroendocrine Society already has an official journal, which of course is the Journal of Neuroendocrinology (JNE). This journal has been the primary presenter of the remarkable e...

What do Flaubert, Dostoevsky and Machado de Assis have in common with neurology?

The Frenchman Gustave Flaubert, the Russian Fyodor Dostoevsky and the Brazilian Machado de Assis are known for their immeasurable contributions to literature. However, what most people do not know is ...

Enrollment in early-phase clinical trials in pediatric oncology: The experience at Institut Curie.

The European Paediatric Regulation was introduced in 2007 to facilitate access to new medicines for children. Our study explored accessibility of early-phase trials in pediatric oncology, in line with...

Clinical Trials [32 Associated Clinical Trials listed on BioPortfolio]

Functional Magnetic Resonance Imaging for High Throughput Curietherapy Planning in Prostate Cancer

Merge the data of ultrasound with that of the anatomical and functional MRI is necessary since the high dose rate Curietherapy is carried out under ultrasound guidance. The investigators w...

Bergonie Institut Profiling : Fighting Cancer by Matching Molecular Alterations and Drugs in Early Phase Trials

This is a biology driven, monocentric study designed to identify actionable molecular alterations in cancer patients with advanced disease. In this trial, high throughput analysis will be...

Institut Paoli Calmettes Myelodysplastic Syndromes Database

Database of Institut Paoli-Calmettes patients diagnosed with Myelodysplastic Syndromes

Study to Validate a Model of Surgical Deescalation in Atypicals Breast Lesions

Routine screening mammography has increased the non-palpable suspicious lesion detection rate, requiring histopathological evaluation. The discovery of atypical lesions on the breast biops...

Trial Evaluating Maintenance Olaparib in Patients With Platinum-sensitive Advanced Non-small Cell Lung Cancer

This is a multicentre randomised double-blind phase II trial, sponsored by Gustave Roussy and involving one French center as well as the Spanish Lung Cancer Group (≈20 centers of the SLC...

Companies [42 Associated Companies listed on BioPortfolio]

Institut Gustave-Roussy

The Institute Gustave-Roussy is a non-profit private institution, exclusively devoted to oncology.It is part of the French public hospital system.State-approved, it is authorised to receive donations ...

Institut Gustave Roussy

The Institut Gustave Roussy (IGR, Villejuif, France), European leading Comprehensive Cancer Center, is a non profit academic entity belonging to the French public hospital service...

WIN Consortium

The WIN Consortium ( is a joint initiative of Institut Gustave Roussy (France) and University of Texas - MD Anderson Cancer Center (USA) which brings togethe...

Statens Serum Institut

Statens Serum Institut is a public enterprise operating as a market-oriented production and service enterprise.Statens Serum Institut is an enterprise under the Danish Ministry of the Interior and Hea...

Institut Pasteur

The Institut Pasteur is a non-profit foundation dedicated to the prevation and treatment of diseases through biological research,education and public health activites

More Information about "Institut Gustave-Roussy" on BioPortfolio

We have published hundreds of Institut Gustave-Roussy news stories on BioPortfolio along with dozens of Institut Gustave-Roussy Clinical Trials and PubMed Articles about Institut Gustave-Roussy for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Institut Gustave-Roussy Companies in our database. You can also find out about relevant Institut Gustave-Roussy Drugs and Medications on this site too.

Quick Search


Relevant Topic

  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Corporate Database Quicklinks

Searches Linking to this Company Record